Harmony Biosciences (NASDAQ:HRMY – Get Free Report) released its earnings results on Tuesday. Harmony Biosciences Price PerformanceHRMY stock opened at $38.99 on Tuesday. Harmony Biosciences has a one year low of $25.52 and a one year high of $40.87. Harmony Biosciences Company Profile(Get Free Report)Harmony Biosciences Holdings, Inc is a commercial‐stage biopharmaceutical company focused on developing and delivering therapies for people with rare neurological and endocrine diseases. Founded in 2017 and headquartered in Plymouth Meeting, Pennsylvania, Harmony Biosciences went public in 2020 and trades on the Nasdaq under the ticker HRMY.